Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: Results of Eastern Cooperative Oncology Group 4593 Conference

Mehta, MP, Tannehill, SP, Adak, S et al. (1998). Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: Results of Eastern Cooperative Oncology Group 4593 . JOURNAL OF CLINICAL ONCOLOGY, 16(11), 3518-3523. 10.1200/JCO.1998.16.11.3518

International Collaboration

cited authors

  • Mehta, MP; Tannehill, SP; Adak, S; Martin, L; Petereit, DG; Wagner, H; Fowler, JF; Johnson, D

sustainable development goals

authors

date/time interval

  • October 26, 1996 -

publication date

  • November 1, 1998

webpage

published in

keywords

  • CARCINOMA
  • CHART
  • CISPLATIN
  • COMBINED CHEMOTHERAPY
  • CONVENTIONAL RADIOTHERAPY
  • FOLLOW-UP
  • HEAD
  • KINETICS
  • Life Sciences & Biomedicine
  • Oncology
  • REGIMEN
  • SURVIVAL
  • Science & Technology

Location

  • LOS ANGELES, CA

Digital Object Identifier (DOI)

Conference

  • 38th Annual Meeting of American-Society-for-Therapeutic-Radiology-and-Oncology

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 3518

end page

  • 3523

volume

  • 16

issue

  • 11